Echo IQ has developed an AI diagnostic tool that will revolutionise the diagnosis of structural heart disease. Specifically, it is designed to reduce the incidence of undetected and misdiagnosed cardiac issues.
Studycast clients can easily leverage AI decision-support for aortic stenosis.
Automated interpretation of echo measurements using AI.
EchoSolv™ AS puts the power of the largest global database of echocardiograms linked to mortality at your fingertips. The only AI in the world built on this database, it has been clinically shown in studies to identify 100% of in-guideline severe aortic stenosis patients.
A study completed at St. Vincent’s Hospital also showed that EchoSolv accurately identified severe aortic stenosis 72% more frequently than human-only diagnosis and that women were 66% less likely to have been accurately diagnosed originally.
EchoSolv is also guideline enabled for Aortic Stenosis, Diastolic Dysfunction and Heart Failure.
Free 12 month no obligation trial
for new EchoIQ customers
Find every single in-guideline severe AS patient, including LFLG and challenging cases, every single time—directly in your Studycast workflow.
Built on an understanding of the complex interrelationships of the whole heart, EchoSolv™ AS offers you decision-support in real time.
1
Fastest AI results – Complete before you start to write your report in Studycast. EchoSolv™ results will be ready for your consideration in under 20 seconds after the study arrives on Studycast.
2
Accurate – Most comprehensive AS check on all your patients: built by cardiologists, EchoSolv’s accuracy is unparalleled.
3
Zero variability – Standardize diagnosis across age, race, sex, and comorbidities.
Trying EchoSolv™ is simple
Simply complete this form and EchoSolv™ will be turned on as soon as you’re ready. With no IT steps required on your part, a member of EchoSolv™ team will reach out to you to confirm right away.
Test EchoSolv™ on both retrospective and live studies. Each study is automatically sent, returning a DICOM image result and a pre-populated field on your Studycast report, allowing you to detect AS in workflow with confidence.
Our clinical validation
St Vincent’s Hospital, Melbourne: EchoSolv™ AS study of 8,257.
By Imelda Cotton - December 15, 2022
Read More
St Vincent’s Hospital, Sydney: EchoSolv AS Study of 9.189
By Imelda Cotton - April 20, 2023
Read More
Enhanced Diagnosis of Severe Aortic Stenosis Using Artificial Intelligence:
A Proof-of-Concept Study of 530,871 Echocardiograms.
By David Playford, Edward Bordin, Razali Mohamad, Simon Stewart, Geoff Strange, April 2020
Read More
Enhanced detection of severe aortic stenosis via artificial intelligence: a clinical cohort study
By Strange G, Stewart S, Watts A, et al, Open Heart 2023
Read More
The highest security and compliance is in place
Start your free trial today
Echo IQ has developed an AI diagnostic tool that will revolutionise the diagnosis of structural heart disease. Specifically, it is designed to reduce the incidence of undetected and misdiagnosed cardiac issues.
#aiwithheart
EchoSolv™ is currently available in the US and Australia as a guideline-led decision-support tool. Full
phenotyping capabilities will be available pending FDA approval.
All rights reserved. Copyright © 2023 Echo IQ.
Designed and Developed by Brand for Brands.